2023

1. Intratumoral co-injection of NK cells and NKG2A-neutralizing monoclonal antibodies

   EMBO Molecular Medicine, Vol. 15, Núm. 11

2. mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy

   Cell Reports Medicine, Vol. 4, Núm. 3